Sebastian Grimm | Associate
IGI
Sebastian is leading the protein engineering division at Ichnos Glenmark Innovation (IGI) in Lausanne. Before, he worked on implementing the yeast display technology at Pieris Pharmaceuticals and developing a T-cell engager platform at Molecular Partners. He performed his post-doctoral research at Dartmouth (NH), holds a PhD in Molecular Biotechnology from the Royal Institute of Technology (KTH) in Stockholm and studied at University of Heidelberg and Technical University of Munich.
Appearances:
Festival of Biologics Day 1 @ 14:50
BEAT®: A Platform to Advance Developable Multispecific Therapeutic Antibodies to the Clinic
IGI’s BEAT platform (Bispecific Engagement by Antibodies based on the TCR) facilitates the design of multi-specific antibodies using efficient heavy-chain heterodimerization and diverse, developable Fabs incorporating a common light chain (cLC). The discovery process from phage display to final format as well as case studies will be presented.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events